BioLine Launches High Performance SensiFAST cDNA Synthesis Kit
2/7/2014 8:30:17 AM
CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the SensiFASTTM cDNA synthesis kit. Powered by a newly developed Reverse Transcriptase enzyme with enhanced properties and in combination with the unique TransAmp™ buffer; SensiFASTTM cDNA synthesis kit is the choice for scientists who need consistent, unbiased, first-strand cDNA synthesis necessary for high sensitivity real-time PCR experiments.
Help employers find you! Check out all the jobs and post your resume.
comments powered by